|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
3 months to Dec 31, 2019
|
|
|---|---|---|---|
| Formation and operating costs | |||
| Revenues | |||
| Cost of revenues | |||
| Operating expenses | |||
| Selling, general and administrative | |||
| Changes in fair value of contingent consideration | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense) | |||
| Interest earned on marketable securities held in Trust Account | |||
| Unrealized loss on marketable securities held in Trust Account | |||
| Other income, net | |||
| Gain on contingent shares issuance liabilities | |||
| Gain on puttable option liabilities | |||
| Interest expense | |||
| Interest expense – Related party | |||
| Total other income (expense) | |||
| Loss before income taxes | |||
| Income tax benefit (expense) | |||
| Net loss and comprehensive loss | |||
| Weighted average shares outstanding, basic and diluted | |||
| Accretion of redeemable convertible preferred stock | |||
| Net loss attributable to common stockholders | |||
| Net loss per share attributable to common stockholders | |||
| Basic (in Dollars per share) | |||
| Diluted (in Dollars per share) | |||
| Weighted-average shares used to compute net loss per share attributable to common stockholders: | |||
| Basic (in Shares) | |||
| Diluted (in Shares) |
Loading...